Free Trial

Trilogy International Partners (TRL) Stock Price, News & Analysis

Today's Range
50-Day Range
52-Week Range
239,291 shs
Average Volume
68,686 shs
Market Capitalization
C$21.27 million
P/E Ratio
Dividend Yield
Price Target
TRL stock logo

About Trilogy International Partners Stock (TSE:TRL)

Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services in New Zealand, Bolivia, and internationally. It offers prepaid and postpaid payment plans, including local, international long distance, and roaming services to customers and international visitors roaming on its networks. The company also provides fixed broadband communications to residential and enterprise customers, as well as a range of mobile and fixed line services in New Zealand and Australia; and fixed public telephony and wireless broadband services in Bolivia. As of December 31, 2021, it had a distribution network of approximately 13 company owned stores, 170 dealers, and 8,300 other dealer points of presence in Bolivia; and a distribution network of approximately 20 company owned retail stores, 40 independent dealers, and 2,500 points of sale through national retail chains and grocery stores in New Zealand. The company's services cover an aggregate population of 16.8 million users. It also provides services through its online self-service store in New Zealand; and operates under the Viva brand name in Bolivia. Trilogy International Partners Inc. was founded in 1982 and is headquartered in Bellevue, Washington.

TRL Stock News Headlines

Musk Issues Urgent Warning…
Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.
Trilogy International Partners Inc TRL.H
Musk Issues Urgent Warning…
Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.
Trilogy International Ltd (TIL)
Trilogy International Partners GAAP EPS of -$0.03
Trilogy International Partners Inc. (TLLYF)
See More Headlines
Receive TRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trilogy International Partners and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Drug Manufacturers - Major
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
C$407.64 million
Cash Flow
C$0.31 per share
Book Value
C$0.38 per share


Free Float
Market Cap
C$21.27 million
Not Optionable
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. John William Stanton B.A. (Age 67)
    BA, M.B.A., MBA, Co-Founder & Chairman
  • Mr. Bradley Jay Horwitz (Age 66)
    Co-Founder, Pres, CEO & Non-Independent Director
    Comp: $772.15k
  • Ms. Theresa E. Gillespie (Age 69)
    Co-Founder & Non-Independent Director
  • Mr. Erik Mickels CPA
    Sr. VP & CFO
  • Mr. Scott Morris
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Mr. Mark Aue
    Chief Exec. Officer of 2degrees
  • Ms. Ann Saxton
    VP of Investor Relations & Corp. Devel.
  • Mr. Juan Pablo Calvo
    Pres of Nuevatel

TRL Stock Analysis - Frequently Asked Questions

How do I buy shares of Trilogy International Partners?

Shares of TRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Trilogy International Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Emera (EMA), Merck & Co., Inc. (MRK), (ONCYF) (ONCYF), AxoGen (AXGN) and A and W Revenue Royalties Income Fund (AW.UN).

This page (TSE:TRL) was last updated on 7/15/2024 by Staff

From Our Partners